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Abstract
Background: Whilst mild neonatal hyponatraemia is common and relatively harmless, extreme hyponatraemia of
95 mmol per litre has never been reported in a premature baby and such a level could be associated with
immediate as well as long-lasting detrimental effects on health.
Case presentation: Twenty-four days old baby boy born at 28 weeks gestation (triplet one) unexpectedly became
moribund with hypovolaemic shock and was found to have blood sodium of 95 mmol per litre. Diagnostic work
up revealed a combination of a urinary tract infection, inadvertently low sodium provision with donor breast milk,
and weak renin-angiotensin-aldosterone response. Commencement of treatment with intravenous fluids and extra
sodium led to unanticipated diuresis and faster than expected increase of sodium level. Ultimately, treatment
resulted in clinical recovery and normalisation of sodium level, which subsequently remained normal with no
additional sodium supplementation. Follow up revealed mild spastic diplegia.
Conclusion: Continuous monitoring and daily medical reviews may not be sensitive enough to recognise
development of extreme hyponatraemia. Blood sodium levels should be monitored closely and any abnormalities
promptly addressed. Treatment of hypovolaemic hyponatraemia should be centred on fluid resuscitation,
anticipation of “paradoxical” diuresis, and blood sodium correction rate of 8 to 10 mmol per litre per day.
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Background
Mild hyponatraemia is common in preterm babies and is
not known to cause significant adverse effects [1]. On
the contrary, extreme hyponatraemia is rarely seen and
increases the risk of neurodisability [2, 3]. Many factors
predispose preterm babies to hyponatraemia: impaired
reabsorption of sodium at both proximal and distal tu-
bules [4], inadequate salt provision, e.g. with donor
breast milk (DBM) [5], immaturity of endocrine mecha-
nisms of water and sodium homeostasis [1, 6].
Reported here is a case of a DBM-fed preterm baby
who developed hypovolaemic shock and extreme hypo-
natraemia of 95 mmol per litre – such a level of hypona-
traemia has not been reported in a premature baby




Baby boy, birth weight 1257 g (close to 75th centile), triplet
one, delivered at 28 weeks gestation by emergency caesar-
ean section for antepartum haemorrhage, in good condition
at birth. On day nine he was weaned off the ventilator onto
nasal continuous positive airway pressure support (CPAP)
and then fully weaned off CPAP by day 23 of life. Except
for episodes of bradycardia on day three of life, which did
not require cardio-pulmonary resuscitation, and slow
weight gain, his progress had been fairly unremarkable. At
the time of presentation he was 24 days old (corrected
gestational age 32 weeks), weight was 1360 g (close to 9th
centile) and he was still nursed in the incubator.
Presentation
On the morning ward round the baby was noted to be irrit-
able with high-pitched cry, pale-mottled skin, and mild skin
tenting on the abdomen. Pulse oximetry readings were
100 % in room air, respiratory rate was 30 – 45 breaths per
minute, heart rate 140 – 145 beats per minute, all peripheral
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pulses were palpable, accurate blood pressure measurement
could not be obtained, there was a formed stool in the
nappy. Serum sodium was 95 mmol per litre (using indirect
ion-specific electrodes [ISE] method), which was corrobo-
rated on the point-of-care analyser (using direct ISE method;
Roche OMNI S, Roche Diagnostics Ltd.): 94.5 mmol per
litre. The latter specimen of blood, when tested in the hos-
pital laboratory, returned a sodium of 95 mmol per litre with
no interference from lipids, blood sugar or proteins; osmo-
lality of the same specimen was measured using freezing
point depression osmometer and was found to be very low -
203 milli-osmoles per kg - consistent with hypotonic hypo-
natraemia and against a factitious cause.
Diagnostic work-up
Table 1 presents standard laboratory data obtained on
presentation, and then 12, 24 and 96 h after treatment ini-
tiation. Figure 1 shows a timeline of blood sodium levels.
From day one of life and until this baby was fully enterally
fed, serum sodium was measured daily (i.e. until day 17).
Sodium level remained within the normal range except for
day 17 when it was 127 mmol per litre. No more measure-
ments were done until day 24 and it was therefore not pos-
sible to describe the rate of sodium drop accurately.
Blood sodium levels depend on sodium and water in-
take and excretion [1]. The excretion is mainly regulated
by antidiuretic hormone (ADH) and renin-angiotensin-
aldosterone system and is geared towards maintenance
of circulatory volume [7]. The intake is regulated by
thirst but in an artificially fed baby would be determined
by the volume and tonicity of feeds [1]. Pathogenesis of
hyponatraemia in this baby has been explored:
1) Sodium dilution due to excessive fluid intake/retention.
Despite receiving between 180 and 200 ml per kg
per day of milk this baby had a rather poor weight
Table 1 Laboratory data
Variable Reference range On presentation 12 h treatment 24 h treatment 4 days treatment
Na (mmol/litre) 135 – 145 94 116 128 134
K (mmol/litre) 3.5 – 5.3 5.2 3.6 4.7 2.8
Creatinine (micromole/litre) 58 – 110 16 24 20 23
Urea (mmol/litre) 2.5 – 7.8 3 1.9 1.5 1.4
Serum osmolality (mosmole/kg) 275 – 295 203 258
Blood glucose (mmol/litre) 3.0 – 7.7 3.9 6.1 4.5
Albumin (g/litre) 35 – 50 34 26 21
Calcium, adjusted (mmol/litre) 2.1 – 2.65 2.55 2.55
Phosphate (mmol/litre) 0.8 – 1.5 1.45 2.46
Chloride (mmol/litre) 95 – 108 68 88 108
pH 7.35 – 7.45 7.36 7.28 7.29 7.35
pCO2 (kPa) 4.5 – 6.1 4.1 5.7 6.1 6.2
Bicarbonate (mmol/litre) 24 – 32 16.8 19.5 21.9 25.3
Base excess (mmol/litre) −2.0 – 2.0 −7.8 −8.2 −5.9 −1.6
Lactate (mmol/litre) 0.4 – 2.2 4.4 1.3
Haemoglobin (g/dl) 11.5 – 16.5 15
White cell count (x109/litre) 5.0 – 18.0 21.3
Neutrophils (x109/litre) 1.5 – 10 10.9
Lymphocytes (x109/litre) 3.0 – 10.0 9.8
Platelets (x109/litre) 150 – 500 262
C-reactive protein (mg/litre) 0.0 – 10.0 2.2 5.5 20.5 3.2
17-OH progesterone (nmol/litre) 0.0 – 20.0 20.9
Cortisol (nmol/litre) not applicable 514
Aldosterone (nmol/litre) 0.083 – 0.44 1.15
Renin (nmol/litre/h) 0.5 – 4.4 >28.8
TSH (μU/ml) 0.35 – 5.5 2.4
Free T3 (pmol/litre) 3.5 – 6.5 3.2
Free thyroxine (pmol/litre) 7.0 – 17.0 11.5
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gain: in 11 days before presentation his weight gain
was a mere 60 g (Fig. 2a), whereas target weight gain
is around 30 g per day [8]. His hydration status on
presentation was described as reduced (mild
abdominal skin tenting) and he had clinical features
of early hypovolaemic shock with vasoconstriction:
tachycardia, pallor, mottled skin and hypothermia
(in the preceding 36 h the incubator temperature
had to be increased from 30 to 32.5 °C). Capillary
blood gas on presentation revealed compensated
metabolic acidosis with raised lactate in keeping
with tissue hypoperfusion (Table 1). In addition,
poor weight gain notwithstanding, albumin was
essentially normal on presentation consistent with
intravascular volume contraction rather than
nutritional sufficiency (Table 1 and Fig. 2b). In the
11 days that followed presentation, as his condition
normalised and sodium deficit replenished, he
gained 540 g (Fig. 2a).
On presentation, a transurethral catheter was passed
and only a very small volume of urine could be
obtained. However, on commencement of treatment
with intravenous 0.9 % sodium chloride (see below),
very brisk urine output was noted averaging 25 ml
per hour in the first five hours. Based on the
available data, the fluid balance over the first 27 h
after presentation and commencement of treatment
was a net loss of 87 ml (Fig. 3). Brisk diuresis has
been described in patients with hypovolaemic
hyponatraemia shortly after the commencement
of treatment, as the expansion of the circulatory
volume improves perfusion, thus inhibiting ADH
and allowing normal osmoreceptor response to low
plasma sodium [9–11].
Taken together, these features argue against sodium
dilution as the sole reason for this baby’s extreme
hyponatraemia, and point to hypovolaemia with
reduced total body sodium. The latter could have
resulted from insufficient intake and/or excessive
losses of sodium.
2) Insufficient sodium intake.
At the time of the hyponatraemic crisis the baby had
been fully enterally fed for a week receiving between
180 and 200 ml per kg per day of donor breast milk
(DBM; derived from two batches) and maternal
expressed milk or low-birth weight formula (Nutriprem
1, Cow&Gate, UK). The ratio of DBM to other milks
was four to one. The reported sodium content of
Nutriprem 1 is 70 mg per 100 ml [12], which converts
to 30 mmol per litre.
Figure 4 shows that the sodium content of DBM he
was fed was half of that in either Nutriprem 1 or
mother’s expressed breast milk (EBM). Thus for the
week preceding presentation with extreme
hyponatraemia he had been receiving between 2.7
and 3.3 mmol per kg of sodium per day. The daily
provision of sodium should be between 4 and
6 mmol per kg per day [13] and therefore this baby’s
sodium provision was short of adequate. This
notwithstanding, suboptimal sodium provision
could not have been the sole explanation of the
extreme hyponatraemia as his triplet sisters, who were
fed DBM in the same ratio with Nutriprem 1 and
Fig. 1 Time line of sodium concentration in the blood. Shaded area represents the normal range (135 – 145 mmol per litre)
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EBM, maintained the serum sodium between 132 and
138 mmol per litre (not shown). Indeed, in the seven
days when his sodium dropped from 127 to 95 mmol
per litre, to avoid the drop his total sodium intake had
to be close to 82 mmol: in these seven days he
received 48 mmol and accrued a deficit of 35 mmol
((127 mM – 95 mM) × 1.36 kg × 0.8 (assuming
extracellular water 80 % of body weight [14]). This
equates to a daily requirement of 9 mmol per kg per
day and indicates that the deficit could be accounted




Fig. 2 Nutritional status. Day 0 stands for day of presentation. a – weight gain/loss over time; PN stands for parenteral nutrition. b – serum
albumin change over time
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3) Sodium losses: where, how much and how?
Review of the baby’s records revealed neither
vomiting nor diarrhoea, and therefore any excessive
sodium loss was via the kidneys. Fractional
excretion of sodium (FENa) has been used to
measure the proportion of filtered sodium that is
excreted in the urine [15]. Values of FENa up to 3 %
were described in critically ill preterm babies
without acute renal failure (ARF) and values 6.9 ±
2.9 % in preterm babies with ARF [16]. At 27 h after
presentation FENa was 1.3 and at 47 h 2.3 %.
However, these figures are difficult to interpret:
during those 47 h the baby received approximately
50 mmol of sodium per kg of weight (Table 2 and
Fig. 5) and FENa is positively related to sodium
provision [7]. The concentration of sodium in the
first urine post presentation was 19 mmol per litre
and osmolality 160 milliosmoles per kg (Table 2) but
it was collected during the phase of brisk diuresis
that followed commencement of treatment with
0.9 % sodium chloride infusion and hence was not
helpful for the analysis of sodium excretion either.
Known causes of sodium loss via kidneys have been
considered below:
a) Congenital adrenal hyperplasia (CAH) could lead
to the deficiency of cortisol and aldosterone
presenting with hyponatraemia, metabolic acidosis,
hyperkalaemia and hypoglycaemia [17]. Urine
steroid profile tested at the time of hyponatraemia
and 48 h later when plasma sodium normalised
found no evidence for any of the inborn errors of
steroid metabolism associated with CAH (Table 4).
In addition, in more than 90 % of CAH, serum
17-α-OH progesterone is markedly elevated but
was essentially normal in this baby and so was
potassium (Table 1). Blood sugar was 3.9 mmol per
Fig. 3 Fluid balance after presentation
Fig. 4 Comparison of sodium concentration in the two batches of DBM, maternal expressed breast milk (EBM) and preterm formula (Nutriprem 1).
Denoted are mean values and ranges (based on two measurements). All measurements were done using Roche OMNI S point-of-care analyser
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litre on presentation but rose briefly to 17.9 within
four hours of treatment before spontaneously
normalising to 5.1 mmol per litre four hours later.
These results, as well as subsequent full recovery,
were decidedly against CAH.
b) Significant electrolyte disturbances have been
described following the use of diuretics [7]. This
baby had never received loop or thiazide
diuretics. In the two weeks before presentation
his only medication had been caffeine base at
2.5 mg/kg once a day orally as treatment of
apnoea of prematurity. Caffeine is known to have
mild diuretic and natriuretic effects [18], however
to our knowledge, at the above dose, has never
been described as a cause of clinically significant
hyponatraemia.
c) Hyponatraemic hypertensive syndrome (HHS)
[19] is caused by unilateral renal ischaemia, most
commonly in neonates due to renal artery
thrombosis following umbilical artery
catheterisation. In this case there was no evidence
of renal ischemia on renal ultrasound scan
performed within 24 h of presentation (not
shown) and whilst there were documented
difficulties in obtaining accurate blood pressure
on presentation, at 20 h of treatment blood
pressure was 51/35 mmHg and baby’s condition
resolved with fluids, electrolytes and antibiotics:
all arguing against the diagnosis of HHS.
d) Urinary tract infection (UTI) in babies can lead
to hyponatraemia due to impairment of tubular
sodium reabsorption (both proximally and
distally) [20]. As epithelial distal channels become
transiently insensitive to aldosterone, its level
goes up reciprocally (pseudohypoaldosteronism).
Affected babies also develop hyperkalaemia and
Table 2 Blood and urine sodium, creatinine, and osmolality, and FENa
Time, hrs Blood Urine FENa, %
Sodium, mmol/l Creatinine, μmol/l Osmolality, mosm/kg Sodium, mmol/l Creatinine, μmol/l Osmolality, mosm/kg
0 94 16 203/207a n/dc
4 112 20 n/ab 19 <880 160 n/a
9 116 24 238 n/d
23 128 20 258/265 n/d
27 127 21 265 93 1110 418 1.3
33 126 17 260 <10 <880 n/a n/a
47 133 17 274 178 980 465 2.3
72 131 34 261/268 37 <880 139 n/a
98 134 23 274 128 1610 440 1.3
aIn italics - calculated osmolality
bn/a – not available
cn/d – not done
Fig. 5 Total sodium supplementation. Day of presentation with hyponatraemia is denoted as day 0
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metabolic acidosis [20]. This baby had a number
of features consistent with UTI. On presentation,
blood and urine (obtained aseptically via
transurethral catheter) were sent off for bacterial
culture and the baby was treated empirically with
intravenous co-amoxiclav and gentamicin. Blood
culture was negative after 5 days of incubation
but urine culture yielded E. coli and Enterobacter
cloacae – both are recognised causes of UTI;
multiple growth in properly collected urine samples
could represent true mixed UTI [21]. Furthermore,
coincidently with the earliest sodium drop (to
127 mmol per litre; day 17 of life) this baby
developed leucocytosis (Table 3). C-reactive
protein (CRP) level was 2.2 mg per litre on
presentation (day 24 of life) but rose to 20.5 by
28 h before falling to 15 mg per litre at 44 h.
Review of CRP and total white cell count of his
triplet sisters showed normal values throughout
their stay on the neonatal unit (not shown).
At the time of presentation serum potassium was
5.2 mmol per litre – upper end of the normal range
(Table 1). This notwithstanding, Nandagopal et al.
described a case of biochemically confirmed
pseudohypoaldosteronism (markedly elevated
aldosterone) in a child with E coli UTI and
hyponatraemia (plasma sodium of 111 mmol per
litre), metabolic acidosis, and potassium of 5.6 mmol
per litre [22]; furthermore, Rodriguez-Soriano et al.
described 32 children with acute pyelonephritis and
normokalaemic pseudohypoaldosteronism [23]. In
the case presented here, serum renin and aldosterone
were not measured until day four of presentation
when the baby had already recovered. Both were
raised, however the level of aldosterone was raised
only slightly and only when compared to the reference
range for infants reported by Nandagopal et al.
(Table 1). Notably, when the two urine steroid profiles
were compared (Table 4), aldosterone metabolites
were only slightly higher in the former sample,
indicative of a rather weak aldosterone response to
the extreme hyponatraemia and hypovolaemia.
This impaired aldosterone response to stimulation
has been described elsewhere and is probably due
to prematurity [6, 24].
An additional feature that developed following the initial
drop of sodium to 127 mmol per litre was metabolic
acidosis. As a rule, premature babies at this stage are
likely to have developed compensated respiratory
acidosis, which was indeed the case with his triplet
sisters (not shown). Contrary to that, at the time of the
extreme hyponatraemia venous blood gas revealed
compensated metabolic acidosis with raised lactate,
which normalised within 48 h of treatment (Table 1).
Serum chloride was low as is often the case with
hyponatraemia and against renal tubular acidosis [25].
4) Proposed pathogenesis of hypovolaemic hyponatraemia
in this baby
Figure 6 charts propositional chain of events, which
lead to hyponatraemia and hypovolaemia in this
baby as inferred from the available data. The events
were triggered by renal sodium loss, probably due to
UTI, and augmented by already weak sodium
reabsorption characteristic of very premature babies
[4]. This led initially to extracellular fluid (ECF)
volume contraction, which maintained sodium at
low-normal level but resulted in poor weight gain.
As the sodium losses continued, circulatory volume
began to contract, which led to activation of
renin-angiotensin system and release of ADH. Thus,
the sodium level was sacrificed in favour of maintaining
circulatory volume. This resulted in small weight gain
and initial drop of sodium (to 127 mmol per litre).
Hyponatraemia was further augmented by the
provision of large volume of hypotonic feeds (DBM).
Sodium losses and inadequate sodium provision
continued and resulted in further exacerbation of
hyponatraemia. This led to the failure of the
intramedullar osmotic gradient and clinically significant
circulatory volume contraction due to impaired renal
response to ADH in this environment [26].
Management of hyponatraemia and hypovolaemia
At the time of presentation, the child’s moribund state,
the extreme degree and unknown duration of hypona-
traemia prompted concerns regarding acute onset hypo-
natraemia with impending brain oedema and associated
risk of encephalopathy and respiratory arrest [27]. For
this reason, in the initial phase of the treatment the aim
was to bring plasma sodium into mild hyponatraemia
range (120 mmol per litre) relatively quickly [28]. The
sodium deficit was estimated at 43.5 mmol ((135 mM –
95 mM) × 1.36 kg × 0.8) and the baby was given 0.9 %
Table 3 C-reactive protein (CRP), white blood cells,
haemoglobin and blood sodium over time
Age (days)
11 13 17 24 26 37 40 46 61
Neutrophils, x109/L 6 11.1 12.4 10.9 n/db n/d n/d 4.2 1.9
WCCa, x109/L 15 21.3 30.3 21.3 n/d 15.9 4.9 16.6 13.4
Hb, g/dL 16.1 n/d n/d 15 n/d 12.8 n/d 11.5 n/d
CRP, mg/L <1 n/d n/d 2.2 20.2 <1 <1 n/d n/d
Sodium, mmol/L 140 137 127 95 131 141 138 138 142
aWCC – total white cell count in the blood
bn/d – not done
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Table 4 Urinary steroid profilea
Steroid Day 0, serum Day 3, serum Mean (SD), (n = 16)
Na = 109 mM Na = 135 mM
3β-Hydroxy-5-ene steroids (microgram per 100 ml)
16α–Hydroxy DHA 335 32 303 (291)
16β–Hydroxy DHA 11 6 149 (111)
16-oxoandrostenediol + 15β,16α-Dihydroxy DHA 330 99 263 (254)
5-androstene-3β,16α,17β-triol 116 27 199 (142)
16α,18-Dihydroxy DHA 119 75 426 (341)
16α-Hydroxypregnenolone 385 3 427 (380)
5-Androstene-3β,16α,17β,18-tetrol 48 18 49 (27)
5-Androstene-3β,15β,16α,17β-tetrol 97 41 82 (62)
5-Androstene-3β,15α,16β,17β-tetrol 53 20 40 (23)
5-Pregnene-3β,16α,20α,21-tetrol 18 5 24 (15)
Cortisol metabolites (microgram per 100 ml)
Tetrahydrocortisone 166 56 108 (85)
α-Cortolone 4 1 32 (53)
β-Cortolone 33 6 20 (17)
1β-Hydroxytetrohydrocortisone 4 2 21 (18)
1β-Hydroxy-β-Cortolone 38 14 25 (22)
6α-Hydroxytetrahydrocortisone 22 16 86 (78)
6α-Hydroxy-α-cortolone 27 10 12 (8)
6α-Hydroxy-β-cortolone 154 67 45 (40)
aall measurements were done at Steroid Profiling Laboratory, Department of Biochemistry, King’s College Hospital, London, UK, which also provided the mean and
standard deviations (SD) based on 16 controls for reference
Fig. 6 Proposed pathogenesis of hypovolaemic hyponatraemia in this baby
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sodium chloride infusion intravenously at 16.6 ml per
hour aiming at bringing sodium level to 120 mmol per
litre within 24 h (increase of around 1 mmol per litre
per hour). Unexpectedly, four hours later serum sodium
was already 112 mmol per litre (i.e. increase of four
mmol per litre per hour) – this was later explained by
brisk diuresis (see above) - so the infusion rate was
halved. In the subsequent 20 h, the rate of plasma so-
dium increase averaged 0.75 mmol per litre per hour.
Figure 5 summarises sodium provision from the eve of
presentation and through the treatment. Any additional
sodium supplementation was gradually reduced and
stopped on day 11 of treatment: serum sodium remained
normal or near normal on all subsequent measurements.
Clinical progress and long term follow up
Irritability and skin mottling resolved within the first
24–36 h of treatment. On day 3 of treatment, a short
episode of twitching of the legs was noted without
change of the heart rate or oxygen saturation: this did
not reoccur and was neither investigated nor treated.
Weight gain, which was fairly static until presentation
despite parenteral nutrition and enteral feeds, improved
significantly shortly after treatment (Fig. 2).
Developmentally, at 24 months, as he became more
mobile, there appeared to be excess circumduction at
the hips along with toe-walking and increased tone in
the legs. The hand use was satisfactory and he showed
good hand-eye coordination. These features were in
keeping with mild diplegic cerebral palsy, typically asso-
ciated with premature birth [29]. This was further cor-
roborated at the age of four years by findings of
periventricular gliosis on magnetic resonance imaging of
the brain (not shown).
Conclusions
Several aspects of this case were instructive and challen-
ging. The duration of hyponatraemia and child’s hydra-
tion status are often cited as the key features on which
to base management [7]. However, both clinical deterior-
ation and extreme hyponatraemia in this baby were
completely unexpected and it was only after several
hours that we were able to infer that hyponatraemia was
probably chronic (i.e. longer than 48 h). The ascertain-
ment of the hydration status was even harder and re-
quired combining clinical features with data on weight
gain, fluid intake, and biochemical parameters: all this
took place at a much later stage.
It has also been noted that cause-specific treatment
should be instituted as soon as possible [30]. However,
the nature of the condition meant that the diagnostic as-
sessment was going to be protracted with turn-around
time for many endocrine tests in excess of two weeks.
The sepsis work up and empirical treatment with
antibiotics were done as part of a routine management
of a sick neonate.
At the time of writing there were no consensus clinical
practice guidelines on diagnosis and treatment of hypona-
traemia in children but there was one for adults [30]. The
authors of the guideline found no specific studies ad-
dressing management of hyponatraemia in patients
with contracted ECF volume and stated that their rec-
ommendations were “based on direct translation of
pathophysiology into clinical practice”. They suggested
that for the replenishment of water and sodium, isotonic
saline was likely to be inferior to balanced crystalloid solu-
tions as it contained very high concentration of chloride,
which could impair renal function. They also felt that the
need for volume resuscitation in haemodynamically un-
stable patients overrode concerns for overly rapid correc-
tion of sodium and suggested that glucose solutions could
be used if “overcorrection was imminent”. Overall pre-
requisite was management in the environment where
close monitoring and ability to monitor sodium frequently
was possible. Authors recommended re-lowering the
serum sodium concentration if it increased by more than
10 mmol per litre during the first 24 h or by more than
8 mmol per litre in any 24 h thereafter. Authors also rec-
ommended obtaining expert advice on the use of
electrolyte-free solutions (such as glucose infusions) and
on the use of intravenous desmopressin.
Clearly, whilst the baby did not come to harm, the so-
dium correction rate was too fast compared to the cor-
rection rate suggested for adults with hypovolaemic
hyponatraemia and had the authors been aware of the
recommendations, it is likely that the sodium correction
rate would have been aimed at 10 – 8 mmol per litre per
day. In addition, we were not aware of the need to an-
ticipate brisk diuresis after the commencement of the
treatment and hence were “caught” by the unexpectedly
fast increase of the sodium level in the blood. Again, it is
likely that we would have contemplated using 5 % glu-
cose infusion instead of 0.9 % sodium chloride as it has
been suggested for adults with this condition [30]. We
state these, fully aware that direct translation of adult-
orientated guidance to premature babies, albeit with a
similar condition, is unlikely to be prudent.
As reported by Shaffer and colleagues, late hyponatrae-
mia and hypovolaemia in premature babies is not uncom-
mon: 6 out of 18 infants born at 32 weeks gestational age
in their series [6]. This finding indicates that in premature
babies endocrine reactions often do not normalize sodium
and water balance but lead to sodium chloride losses; this
could be due to weak response of the premature adrenal
glands [1]. This, as well as other peculiarities such as weak
reabsorption in proximal and distal tubules [1, 4], high
rate of urinary sodium excretion in sodium-restricted in-
fants [31], weak concentrating ability of the kidneys [32],
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call for evidence-based hyponatraemia guidance applied to
children and premature babies specifically. We hope the
case reported here would contribute to that goal.
Consent
Written informed consent was obtained from the par-
ents of this baby for publication of this case report and
any accompanying images. A copy of the written consent
is available for review by the Editor of this journal.
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